These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23552807)
41. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy. Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756 [TBL] [Abstract][Full Text] [Related]
42. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy. Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497 [TBL] [Abstract][Full Text] [Related]
43. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer. Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502 [TBL] [Abstract][Full Text] [Related]
44. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522 [TBL] [Abstract][Full Text] [Related]
45. [Investigation of prognostic factor and treatment mode for undifferentiated cervical carcinoma]. Zhang Y; Li M; Wang H Zhonghua Fu Chan Ke Za Zhi; 2000 Jan; 35(1):45-7. PubMed ID: 11831951 [TBL] [Abstract][Full Text] [Related]
46. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome. van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347 [TBL] [Abstract][Full Text] [Related]
47. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy. Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594 [TBL] [Abstract][Full Text] [Related]
48. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review. Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556 [TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB. Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760 [TBL] [Abstract][Full Text] [Related]
50. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix. Datta CK W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143 [TBL] [Abstract][Full Text] [Related]
51. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis. Ceballos KM; Shaw D; Daya D Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058 [TBL] [Abstract][Full Text] [Related]
52. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery. Bean LM; Ward KK; Plaxe SC; McHale MT Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318 [TBL] [Abstract][Full Text] [Related]
53. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma. Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716 [TBL] [Abstract][Full Text] [Related]
54. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094 [TBL] [Abstract][Full Text] [Related]
55. Mucinous adenocarcinoma of the endometrium: case series and review of the literature. Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408 [TBL] [Abstract][Full Text] [Related]
57. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [TBL] [Abstract][Full Text] [Related]
58. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. Wertheim MS; Hakes TB; Daghestani AN; Nori D; Smith DH; Lewis JL J Clin Oncol; 1985 Jul; 3(7):912-6. PubMed ID: 2410573 [TBL] [Abstract][Full Text] [Related]
59. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related]
60. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients. Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]